⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AI Visibility Scorecard
EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option
hepctreated.com · Healthcare
Borderline visible. AI bots can crawl EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 4 times
Apple Intelligence · Claude · Meta AI
#762,536 of 859,437 in Healthcare for AI visibility
3
AEO Visibility
iNear-invisible · 3.3/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
About EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option
from our crawl and measurement
"Discover EPCLUSA® (sofosbuvir/velpatasvir), a prescription medicine used to treat chronic Hep C. See Important Safety Information including Important Warning." That is how EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option introduces itself. When AI engines look at it, they find little to work with. It scores 3.3 out of 10.
The site is missing structured data describing the business, an llms.txt file and a sitemap.
AI crawlers have visited 3 times in our tracking, including ClaudeBot (Anthropic) and Applebot (Siri).
The 6 signals AI reads
Higher is better · 0-10
Structured Data
1
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
5
Clear headings and answer-style content.
Entity Clarity
4
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
1
Experience, Expertise, Authority, Trust markers.
Technical AEO
6
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
6
Sitemaps and entity links AI can follow.
Off-page authority
How the web signals your brand to AI
Backlinks
1
Inbound links from other sites.
Domain Authority
0
Little domain authority yet.
Reference Presence
0
Not in AI knowledge graphs yet.
News & Press
0
No press coverage found yet.
Community
0
No community discussion yet.
Social Mentions
0
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 3.3/10, EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option is crawlable but under-signaled - fixable, and the signals above are where to start.
Is this your brand?
The exact fixes for EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option.
Source & Attribution
Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/hepctreated
Cite this score: Engagemii (2026). "AEO Score for EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option." Retrieved from https://engagemii.com/aeo/brands/hepctreated
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform